http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2529075-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ec3985e3ce9b24614fb87bf51a4f12 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0083 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00 |
| filingDate | 2011-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88393d0e89747783bceac6dec0087f04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4626592dc7703e1c33bc24bc55cd5d9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae397512ef95fc7270af27b09ee08449 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_219ac4c16b5d7a42c0e847dc6a523fc5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb32c2cc96a6ae052af5e6656abe6f20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a66fbaaa9b722d0c2f46b5e4985c72ab |
| publicationDate | 2015-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2529075-T3 |
| titleOfInvention | Progesterone receptor antagonist agents |
| abstract | Compounds of the formula I ** Formula ** wherein R1 represents either a radical Y or a phenyl ring substituted with Y, ** Formula ** Y represents a group R2 and R3 are the same or different and represent hydrogen, a C1-C6 alkyl radical, optionally substituted with N (CH3) 2, ** Formula ** or - NHC (O) CH3, ** Formula ** a radical or a 6-10 membered aryl radical, which is eventually substituted once, twice or multiple times with halogen (-F, -Cl, -Br, -I), -OH, -O-alkyl, -C (O) OH, -C (O) O-alkyl, -C (O) NH2, -C (O) NH-alkyl, -C (O) N-dialkyl, -C (O) NH-aryl, -C (O) NH-heteroaryl, -NH2, -NH (C1 alkyl -C6), -N (C1-C6 alkyl) 2, in particular with -N (CH3) 2, -NHC (O) -alkyl, -NO2, -N3, -CN, -C1-C6 alkyl, - perfluoro-C1-C6 alkyl, -C1-C6 acyl, -C1-C6 acyloxy, -SO2NH2, -SO2NH-alkyl or -SO2N-dialkyl, a 5-10 membered heteroaryl radical, which is eventually substituted once , twice or multiple times with the substituents of the aryl radical d e 6-10 members mentioned above, a C1-C6 arylalkyl radical, which is optionally substituted next to the aryl ring once, twice or multiple times with the substituents of the 6-10 member aryl radical which more above, or a C1-C6 heteroarylalkyl radical, which is optionally substituted by the heteroaryl ring once, twice or multiple times with the 6-10 membered aryl radical substituents mentioned above, or but R2 and R3 in common are a component part of a 3-10 membered ring that is optionally substituted by a carbon with alkyl, carboxyl, alkoxycarbonyl, alkylcarbonyl, aminocarbonyl, aryl, in particular with phenyl, arylalkyl, heteroaryl, heteroarylalkyl, aminoalkyl or dimethylaminoalkyl, or respectively together with a nitrogen with alkyl, alkanoyl, carboxyl, alkoxycarbonyl, aryl, in particular with phenyl, pyridinyl, pyrimidinyl, pyrazinyl, sul Fonyl, benzoyl, alkylsulfonyl, arylsulfonyl, aminocarbonyl, dimethylaminocarbonyl, aminocarbonylalkyl, alkylaminocarbonylalkyl, arylalkyl, in particular with phenylalkyl, heterocyclylalkyl, heteroarylalkyl, aminoalkyl or, ** Formula which may eventually be nitrogen, which may be oxygen, which may be nitrogen, which may be oxygen, which may be oxygen, which may be oxygen, which may be oxygen, which may be oxygen oxidized to give the sulfoxide or the sulfone, possibly an aromatic radical being condensed next to the 3-10 membered ring, X means an oxygen atom, NOR4 or NNHSO2R4 and R4 is chosen from the group comprising hydrogen, C1- alkyl C6 and aryl, and their salts, solvates or solvates of the salts including all crystalline modifications (the * symbolizes the site of attachment to the fundamental framework). |
| priorityDate | 2010-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 313.